A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 2,887 shares of CRL stock, worth $466,654. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,887
Holding current value
$466,654
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $542,640 - $708,152
2,887 New
2,887 $568,000
Q2 2024

Aug 06, 2024

SELL
$206.39 - $268.73 $151,490 - $197,247
-734 Reduced 18.21%
3,297 $681,000
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $294,900 - $396,200
1,449 Added 56.12%
4,031 $1.09 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $36,029 - $52,305
219 Added 9.27%
2,582 $610,000
Q3 2023

Nov 08, 2023

BUY
$194.44 - $217.61 $179,079 - $200,418
921 Added 63.87%
2,363 $463,000
Q2 2023

Aug 04, 2023

SELL
$183.71 - $210.25 $20,024 - $22,917
-109 Reduced 7.03%
1,442 $303,000
Q1 2023

May 09, 2023

BUY
$191.89 - $259.92 $53,921 - $73,037
281 Added 22.13%
1,551 $313,000
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $11,235 - $14,253
57 Added 4.7%
1,270 $276,000
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $3,101 - $4,259
-17 Reduced 1.38%
1,213 $239,000
Q2 2022

Aug 08, 2022

BUY
$204.13 - $302.4 $24,903 - $36,892
122 Added 11.01%
1,230 $263,000
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $39,604 - $56,127
-155 Reduced 12.27%
1,108 $321,000
Q4 2021

Feb 15, 2022

BUY
$351.38 - $448.68 $9,838 - $12,563
28 Added 2.27%
1,263 $475,000
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $9,316 - $11,457
25 Added 2.07%
1,235 $510,000
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $355,945 - $449,696
1,210 New
1,210 $448,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.22B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.